Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00875
|
|||||
| Drug Name |
Pridopidine
|
|||||
| Synonyms |
Huntexil; 346688-38-8; 4-(3-(Methylsulfonyl)phenyl)-1-propylpiperidine; 4-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine; 4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine; ACR 16; ACR-16; ACR16; AJ-80925; AKOS015891431; AS-50146; ASP 2314; ASP-2314; AX8258340; BDBM50308028; CHEMBL596802; CS-0002733; CTK4H2809; DB-014417; DB11947; DTXSID90188225; Dopamine modulator (Huntingtons disease), Carlsson Research; Dopamine modulator (Huntingtons disease), NeuroSearch; Dopamine modulator (neurological disorders), Merck & Co; Dopamine modulator (schizophrenia), Astellas; Dopamine modulator (schizophrenia), Fujisawa; FR 310826; FR310826; FT-0672149; HD4TW8S2VK; HY-10684; NCGC00386586-01; PRIDOPIDINE; Pridopidine (USAN/INN); Pridopidine [USAN:INN]; Pridopidine hydrochloride; SCHEMBL166748; UNII-HD4TW8S2VK; ZINC22063703
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H23NO2S
|
|||||
| Canonical SMILES |
CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C
|
|||||
| InChI |
InChI=1S/C15H23NO2S/c1-3-9-16-10-7-13(8-11-16)14-5-4-6-15(12-14)19(2,17)18/h4-6,12-13H,3,7-11H2,1-2H3
|
|||||
| InChIKey |
YGKUEOZJFIXDGI-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 346688-38-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 281.4 | Topological Polar Surface Area | 45.8 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
2.6
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.